GeminIQ Website Logo

Viewing BQST free

Start free trial

Subscribe for full history, 90+ metrics, screener, watchlist...

Bioquest Corp

BQST

Companies in Pharmaceutical Preparations

LLYJNJABBVMRKABTPFE

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

Values in Millions ($)
2022-07-31
2022-04-30
2022-01-31
2021-10-31
2021-07-31
2021-04-30
2021-01-31
2020-10-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
00000000
Assets Current
Assets Current
00000000
Prepaid Expense Current
---00000
Assets
00000000
Liabilities And Stockhold…
Accounts Payable And Accrued Liabilities Current
00000001
Liabilities Current
Liabilities Current
10002211
Employee Related Liabilities Current
----211-
Due To Officers Or Stockholders Current
00--00--
Interest Payable Current
000000--
Notes Payable Current
---0--00
Convertible Notes Payable Current
000-00--
Derivative Liabilities Current
0000000-
Liabilities
10002201
Liabilities Noncurrent
Long Term Notes Payable
------00
Accumulated Other Comprehensive Income Loss Net Of…
--------8
Common Stock Value
00000000
Stockholders Equity
Stockholders Equity
-1-0-0-0-2-2-1-1
Additional Paid In Capital Common Stock
101010108888
Retained Earnings Accumulated Deficit
-11-11-10-10-10-10-0-
Liabilities And Stockholders Equity
00000000
Debt Instrument Unamortized Discount Current
-0000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
500500500500500500500500
Common Stock Shares Issued
111111119988
Shares Outstanding
111111119988

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2023-88.21%-88.09%-86.11%---------
20220.00%-92.31%-90.38%0.00%-3.85%-80.77%-92.31%-90.38%-78.85%763.64%1.82%2.82%
2021----42.25%-8.45%-49.30%-25.00%-25.00%-40.00%0.00%26.67%25.00%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics
2022-07-31
2022-04-30
2022-01-31
2021-10-31
2021-07-31
2021-04-30
2021-01-31
2020-10-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.03
0.07
0.00
0.02
0.01
0.01
0.02
0.02
Quick Ratio
0.03
0.07
0.00
0.00
0.00
0.00
0.00
0.00
Working Capital
-536.42K
-432.99K
-393.56K
-443.65K
-2.14M
-1.77M
-1.41M
-763.09K
Leverage & Debt
Debt to Equity
-1.03
-1.08
-1.00
-1.02
-1.01
-1.01
-0.27
-1.02
Interest Coverage TTM
-9.88
-13.12
-13.78
-17.21
-22.84
-43.43
-165.87
-3,215.95
Debt Ratio
36.87
13.91
3,393.74
65.71
152.09
104.50
17.65
50.36
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.07
Per Share Metrics
Diluted EPS TTM
-
-0.08
-0.14
-
-
-0.39
-0.37
-
Free Cash Flow Per Share TTM
-0.01
-0.01
-0.01
-0.01
-0.03
-0.12
-0.19
-0.23
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Operating Profit Margin TTM
-
-
-
-
-
-269,231.42%
-9,635.66%
-7,812.93%
Net Profit Margin TTM
-
-
-
-
-
-279,873.44%
-9,975.07%
-11,510.97%
Growth Metrics
Net Revenue Growth (1Y)
-
-100.00%
-100.00%
-100.00%
-100.00%
-96.14%
-
-
Net Income Growth (1Y)
-81.62%
-74.54%
-48.18%
-34.97%
-19.16%
28.20%
90.03%
630.70%
EPS Growth (1Y)
-85.79%
-80.34%
-61.76%
-43.52%
1,406.07%
2,201.20%
4,144.41%
19,241.28%
Valuation Metrics
P/E TTM
-21.00
-7.16
-3.67
-3.05
-2.38
-2.71
-5.27
-9.64
P/B TTM
-19.86
-13.58
-14.94
-15.92
-3.07
-4.93
-11.26
-42.78
P/S TTM
-
-
-
-
-
7,578.76
525.36
1,109.16
Market Cap
10.66M
5.88M
5.88M
7.06M
6.57M
8.73M
16.27M
34.36M
Enterprise Value
10.82M
6.03M
5.92M
7.12M
6.61M
8.80M
16.33M
34.41M
Calculated Values
Free Cash Flow TTM
-72.78K
-116.72K
-70.24K
-112.55K
-255.73K
-1.07M
-1.59M
-1.91M
Net Debt
168.35K
149.76K
39.88K
57.48K
37.26K
73.94K
57.18K
52.64K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Start free trial
No insider data available.

Subscribe to unlock 17+ years of data

Start free trial
No institutional ownership data available.

Bioquest Corp (BQST) — SEC Financial Statements & Analysis

Bioquest Corp (BQST) is a pharmaceutical preparations company, incorporated in NV. Bioquest Corp trades on OTC as: BQST. Based on its latest SEC filing (Form 10-Q, period ending 2022-07-31), Bioquest Corp reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of -1.03x, a Price-to-Sales (P/S) ratio of 7578.76x (TTM), a Price-to-Book (P/B) ratio of -19.86 (TTM), at a market cap of $10.66M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-100.00%
Debt To Equity
-1.03x
P/S TTM
7578.76x
P/B TTM
-19.86
Market Cap
$10.66M

Data as of 2022-07-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Bioquest Corp in?

Bioquest Corp (BQST) operates in the Pharmaceutical Preparations industry.

What is BQST's market cap?

Bioquest Corp (BQST) has a market capitalization of $10.66M as of 2022-07-31.

What exchange does BQST trade on?

Bioquest Corp (BQST) trades on the OTC.

Where is Bioquest Corp incorporated?

Bioquest Corp is incorporated in NV.

Research Faster.
Invest Smarter.

Start 7-day free trial

Bioquest Corp (BQST) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 90+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.